Glypican 2 As A Cancer Marker And Therapeutic Target
Japan
2023-133443
Filed on 2016-11-08
2023-133443
Filed on 2016-11-08
Directed acetylation of mRNA through engineered snoRNA adapters
Patent Cooperation Treaty
PCT/US2023/078830
Filed on 2023-11-06
PCT/US2023/078830
Filed on 2023-11-06
TOPOISOMERASE Ill (TOP3) INHIBITORS AND ANTIVIRAL COMPOUNDS BASED ON CYANINES
Patent Cooperation Treaty
PCT/US2023/081638
Filed on 2023-11-29
PCT/US2023/081638
Filed on 2023-11-29
Topoisomerase Ill (TOP3) inhibitors and antiviral compounds based on bisacridines
Patent Cooperation Treaty
PCT/US2023/082186
Filed on 2023-12-01
PCT/US2023/082186
Filed on 2023-12-01
CANCER VACCINE AND METHOD OF USE THEREOF
US Application 18/550,895
Filed on 2023-09-15
Filed on 2023-09-15
IMPLICATIONS OF CXCR3 EXPRESSION ON MYELOID CELLS FOR IMMUNOTHERAPY OFCANCER AND MYELOID-MEDIATED DISEASES
Patent Cooperation Treaty
PCT/US2023/078854
Filed on 2023-11-06
PCT/US2023/078854
Filed on 2023-11-06
T CELL RECEPTORS RECOGNIZING MUTATED P53
Eurasian Patent
202392526
Filed on 2023-10-06
202392526
Filed on 2023-10-06
Methods and Compositions for Inducing an Immune Response Using Conserved Element Constructs
Switzerland
16725323.6
Filed on 2016-05-13
16725323.6
Filed on 2016-05-13
Methods and Compositions for Inducing an Immune Response Using Conserved Element Constructs
United Kingdom
16725323.6
Filed on 2016-05-13
16725323.6
Filed on 2016-05-13